SD

Seema Devi

Active Director Director DIN 09385189
DIN 09385189 First appointment Nov 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Seema Devi

Data last updated:

Seema Devi is a Director at Allioth Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Allioth Pharmaceuticals Private Limited reported revenue of ₹21.4 Lakh (FY 2025).

DIN 09385189
Primary Designation Director
Industry Trading
First Appointment 01 Nov 2021
Oldest Company Age 4 yrs
Largest company Allioth Pharmaceuticals Private Limited · ₹21.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Nov 20212021₹21.4 Lakh (FY 2025)Active

Board colleagues of Seema Devi

NameDINCompanyDesignation
Aarti Sharma09385188Allioth Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Allioth Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Seema Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Devi

Seema Devi currently holds 1 directorship: Allioth Pharmaceuticals Private Limited (Director, since 01 Nov 2021, revenue ₹21.4 Lakh (FY 2025)).

Seema Devi was first appointed on 01 Nov 2021 as Director at Allioth Pharmaceuticals Private Limited.

The current boards of Seema Devi's companies include Aarti Sharma (Allioth Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available